Featured

VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV) just announced the details of its long awaited phase III program in hepatitis B. The program, if successful, will underpin registration applications for VBI's lead hepatitis B asset in the US, Europe and Canada and – as such – its initiation is...

We think Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (including cannabis derived chemicals) for neuropathic pain is worthy of a close look. Cannabis regulation has been relaxing both globally and in the United States and this influences our stance on CARA stock....

The share price of TEMPUS APPLIED SOLUTION HOLDINGS (OTCMKTS:TMPS) has soared over the last 5 days from a low of under $0.05 to a high of $0.50 on 6/19/17. Investors interest in TMPS is due to the recent purchase of the controlling portion by billionaire Johan Eliasch. a little info...

OUR NEW PROFILE IS: SRUP Worldwide cybersecurity market grew from $3.5 billion in 2004 to $75 billion in 2015, forecasted to reach $170 billion by 2020. We are all living in the age of never before seen cybercriminal activity, so large in fact that it is nearly impossible to accurately track. Good...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing...